相关上市企业：华北制药（600812）、石药集团（01093）、鲁抗医药（600789）、九典制药 （300705）、康恩贝（600572）、新华制药（000756）、华海药业（600521）、福瑞达（600223）、汤 臣倍健（300146）等。 相关企业：华北制药威可达有限公司、宁夏金维制药股份有限公司、河北华荣制药有限公司、玉锋实业 集团有限公司、湖南先施制药有限公司、山东益康药业股份有限公司、南京海纳制药有限公司等。 内容概要：维生素B12作为人体至关重要的水溶性维生素，具有营养神经、预防恶性贫血的作用，可用 于治疗脑出血、脑梗死、阿尔茨海默病、帕金森病、急性脊髓炎、巨幼细胞性贫血等疾病。随着消费者 对健康意识的提高，维生素B12等营养补充剂的市场需求不断增加。据统计，2024年中国钴胺素行业市 场规模达到14亿元，同比上涨6%。 关键词：钴胺素行业产业链、钴胺素行业市场规模、钴胺素行业出口数量、钴胺素行业竞争格局、钴胺 素行业发展趋势 一、钴胺素行业相关概述 钴胺素又叫维生素B12，是唯一含金属元素的维生素。维生素B12为红色结晶粉末，无嗅无味，溶于 水，难溶于乙醇，不溶于丙酮、氯仿和乙醚，在pH值 ...

Core Viewpoint - The article discusses the advancements in the production of 1,3-propanediol (1,3-PDO) using engineered strains of Klebsiella pneumoniae, highlighting significant improvements in yield and efficiency through metabolic engineering and strain evolution [2][20][23]. Summary by Sections 1. Production Methodology - 1,3-PDO is a high-value fine chemical used in cosmetics, pharmaceuticals, and plastics, traditionally produced through chemical synthesis, which involves toxic substances and high pressure. Microbial fermentation has emerged as a more economical and environmentally friendly production method [2]. - The research team led by Professor Liu Liming achieved a production yield of 138.6 g/L of 1,3-PDO using the engineered strain FMME-51, with a conversion rate of 0.52 g/g, without the need for additional VB12 [2][20]. 2. Strain Optimization - Initial strain FMME-01 produced 67.2 g/L of 1,3-PDO but generated multiple by-products that reduced yield. Subsequent modifications led to strain FMME-14, which showed improved production performance [6]. - Further optimization of the cell membrane composition in strain FMME-38 resulted in a 62.5% increase in tolerance to high 1,3-PDO concentrations and a 41.2% reduction in cell death [9][10]. 3. Enhancements in Co-Factor Synthesis - The production process relies on VB12 and NADH. The integration of genes responsible for VB12 synthesis into the genome of strain FMME-48 resulted in a VB12 concentration of 50.8 μg/L and a 1,3-PDO yield of 118.3 g/L [14]. - The dynamic regulation of NADH levels was achieved through the construction of a biosensor-based system, enhancing the NADH/NAD⁺ ratio by 31.3% in strain FMME-51, leading to a 12.3% increase in 1,3-PDO yield [18][14]. 4. Process Optimization - The optimization of glycerol feeding rates and pH levels significantly improved the production performance of strain FMME-51, achieving a 1,3-PDO yield of 135.9 g/L at a pH of 6.8 [19]. - The final optimized strain FMME-51 demonstrated a production capacity of 122.7 g/L of 1,3-PDO using low-cost crude glycerol as a substrate, showcasing its industrial potential [20][23]. 5. Industrial Implications - The research indicates a significant advancement in the bioproduction of 1,3-PDO, achieving unprecedented yields and efficiencies while eliminating the need for expensive co-factors, thus reducing production costs [20][23]. - The ability of engineered strain FMME-51 to efficiently utilize crude glycerol highlights its potential for large-scale industrial applications in the production of high-value chemicals [23].